Scaleable catalog AstaTech offers a substantial catalog of over 100,000 advanced intermediates and drug-like building blocks, with 10% scalable to kg to MT scales. This suggests a strong upsell opportunity to customers needing scalable synthesis and supply chain reliability for late-stage development or small-to-large scale manufacturing.

PhD driven expertise With more than 40percent of chemists holding PhDs or MS degrees and a long track record since 1996, AstaTech can position as a high-precision CRO partner for complex synthetic routes and tightly controlled quality, appealing to pharmaceutical and biotech firms seeking sophisticated chemistry solutions.

Global customer reach Serving 10,000 customers worldwide indicates broad market exposure and potential for multi-region account expansion, strategic partnerships, and cross-sell of related services such as discovery chemistry, process development, and manufacturing scale-up.

Integrated capabilities Combining chemistry expertise with manufacturing capabilities enables end-to-end support from drug discovery to manufacturing, presenting a compelling value proposition for customers seeking streamlined vendor management and reduced time to market.

Revenue growth potential Current revenue range ($50M–$100M) and recent funding ($30M) imply investment in capacity and technology. This supports targeting mid-to-late-stage programs and labs seeking reliable chemistry CRO partners with scalable output and competitive pricing.